Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU

Lourens T. Bloem; Aukje K. Mantel-Teeuwisse; Hubert G. M. Leufkens; Marie L. De Bruin; Olaf H. Klungel; Jarno Hoekman

Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU

Lourens T. Bloem, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens, Marie L. De Bruin, Olaf H. Klungel, Jarno Hoekman

Copenhagen Centre for Regulatory Science

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

Originalsprog	Engelsk
Publikationsdato	aug. 2017
Status	Udgivet - aug. 2017
Begivenhed	33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, - Varighed: 26 aug. 2017 → 30 aug. 2018

Konference

Konference	33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,
Periode	26/08/2017 → 30/08/2018

Adgang til dokumentet

https://onlinelibrary.wiley.com/toc/10991557/2017/26/S2Licens: Ikke-specificeret

Citationsformater

Bloem, L. T., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., De Bruin, M. L., Klungel, O. H., & Hoekman, J. (2017). Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU. 605-605. Abstract fra 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,. https://onlinelibrary.wiley.com/toc/10991557/2017/26/S2

Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU. / Bloem, Lourens T.; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M. et al.
2017. 605-605 Abstract fra 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

Bloem, LT, Mantel-Teeuwisse, AK, Leufkens, HGM, De Bruin, ML, Klungel, OH & Hoekman, J 2017, 'Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU', 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 26/08/2017 - 30/08/2018 s. 605-605. <https://onlinelibrary.wiley.com/toc/10991557/2017/26/S2>

@conference{6422294e8c734fefad6977404fa922ff,

title = "Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU",

author = "Bloem, {Lourens T.} and Mantel-Teeuwisse, {Aukje K.} and Leufkens, {Hubert G. M.} and {De Bruin}, {Marie L.} and Klungel, {Olaf H.} and Jarno Hoekman",

year = "2017",

month = aug,

language = "English",

pages = "605--605",

note = "33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, ; Conference date: 26-08-2017 Through 30-08-2018",

}

TY - ABST

T1 - Risk Factors Associated with Post-Marketing Changes in Specific Obligations of Conditionally Authorised Products in the EU

AU - Bloem, Lourens T.

AU - Mantel-Teeuwisse, Aukje K.

AU - Leufkens, Hubert G. M.

AU - De Bruin, Marie L.

AU - Klungel, Olaf H.

AU - Hoekman, Jarno

PY - 2017/8

Y1 - 2017/8

M3 - Conference abstract for conference

SP - 605

EP - 605

T2 - 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,

Y2 - 26 August 2017 through 30 August 2018

ER -